These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18765711)

  • 1. Effect of testosterone therapy versus other factors on the self-reported sexual satisfaction of premenopausal women.
    Kumar H; Muthukrishnan J; Modi KD
    Ann Intern Med; 2008 Sep; 149(5):361; author reply 361-2. PubMed ID: 18765711
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Testosterone therapy versus other factors on the self-reported sexual satisfaction of premenopausal women.
    Hong L; Wu K; Fan D
    Ann Intern Med; 2008 Sep; 149(5):361; author reply 361-2. PubMed ID: 18765712
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial.
    Davis S; Papalia MA; Norman RJ; O'Neill S; Redelman M; Williamson M; Stuckey BG; Wlodarczyk J; Gard'ner K; Humberstone A
    Ann Intern Med; 2008 Apr; 148(8):569-77. PubMed ID: 18413618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which Postmenopausal Women Should Use Testosterone for Low Sexual Desire?
    Slomski A
    JAMA; 2020 Feb; 323(6):493-495. PubMed ID: 31968073
    [No Abstract]   [Full Text] [Related]  

  • 5. Testosterone supplementation to improve women's sexual satisfaction: complexities and unknowns.
    Basson R
    Ann Intern Med; 2008 Apr; 148(8):620-1. PubMed ID: 18413624
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgen Therapy in Women.
    Vegunta S; Kling JM; Kapoor E
    J Womens Health (Larchmt); 2020 Jan; 29(1):57-64. PubMed ID: 31687883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
    Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Tribulus Terrestris for the treatment of premenopausal women with hypoactive sexual desire disorder: a randomized double-blinded, placebo-controlled trial.
    Vale FBC; Zanolla Dias de Souza K; Rezende CR; Geber S
    Gynecol Endocrinol; 2018 May; 34(5):442-445. PubMed ID: 29172782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal testosterone gel prn application for hypoactive sexual desire disorder in premenopausal women: a controlled pilot study of the effects on the arizona sexual experiences scale for females and sexual function questionnaire.
    Chudakov B; Ben Zion IZ; Belmaker RH
    J Sex Med; 2007 Jan; 4(1):204-208. PubMed ID: 17233786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is there a pharmacotherapy for libido disturbances in men?].
    Köhn FM
    Urologe A; 2006 Aug; 45(8):999-1001. PubMed ID: 16832642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
    Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
    J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study identifies effective testosterone dose for women.
    Harv Womens Health Watch; 2014 Nov; 22(3):8. PubMed ID: 26080465
    [No Abstract]   [Full Text] [Related]  

  • 13. New Drug for Hypoactive Sexual Desire Disorder in Premenopausal Women.
    Aschenbrenner DS
    Am J Nurs; 2019 Oct; 119(10):21. PubMed ID: 31567244
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B: Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction.
    Guay A; Jacobson J; Munarriz R; Traish A; Talakoub L; Quirk F; Goldstein I; Spark R
    Int J Impot Res; 2004 Apr; 16(2):121-9. PubMed ID: 14973532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case series of androgen use in breast cancer survivors with sexual dysfunction.
    Krychman ML; Stelling CJ; Carter J; Hudis CA
    J Sex Med; 2007 Nov; 4(6):1769-74. PubMed ID: 17666036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
    Schover LR
    Fertil Steril; 2008 Jul; 90(1):129-40. PubMed ID: 18023435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal factors in female sexual dysfunction.
    Anastasiadis AG; Davis AR; Salomon L; Burchardt M; Shabsigh R
    Curr Opin Urol; 2002 Nov; 12(6):503-7. PubMed ID: 12409881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen status in healthy premenopausal women with loss of libido.
    Nyunt A; Stephen G; Gibbin J; Durgan L; Fielding AM; Wheeler M; Price DE
    J Sex Marital Ther; 2005; 31(1):73-80. PubMed ID: 15841707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone patches for female sexual dysfunction.
    Drug Ther Bull; 2009 Mar; 47(3):30-4. PubMed ID: 19261838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder.
    White WB; Grady D; Giudice LC; Berry SM; Zborowski J; Snabes MC
    Am Heart J; 2012 Jan; 163(1):27-32. PubMed ID: 22172433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.